Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 25, 2026

AMD and Nutanix Announce Strategic Partnership to Advance an Open and Scalable Platform for Enterprise AI

View original at globenewswire.com
AMD and Nutanix Announce Strategic Partnership to Advance an Open and Scalable Platform for Enterprise AI News Highlights AMD and Nutanix sign multi-year agreement to accelerate adoption of Nutanix-powered agentic AI platform on AMD accelerated compute infrastructure for enterprise AI and service providers AMD to inves…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AMD technology powers billions of experiences across cloud and AI infrastructure, embedded systems, AI PCs and gaming

    80% confidence

  • Enterprise AI infrastructure is entering a phase where inference workloads dominate and openness is essential for long-term innovation

    80% confidence

  • Through partnership with Nutanix, AMD is building a scalable, full-stack AI platform rooted in openness, designed to give enterprises and service providers flexibility to innovate, extend and grow AI deployments

    80% confidence

  • Enterprise customers need the freedom to run the models and workloads that matter most to their business, without compromise

    80% confidence

  • First jointly-developed agentic AI platform expected to come to market beginning in late 2026

    80% confidence

  • AMD is committed to advancing an AI ecosystem built on open standards, interoperable software frameworks and architectural choice

    80% confidence

  • Partnership with AMD reflects a shared vision for scalable, production-ready AI infrastructure

    80% confidence

  • Together, AMD and Nutanix are delivering full-stack, integrated platforms optimized for inference and agentic applications across hybrid environments for enterprises and service providers

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com